Company Filing History:
Years Active: 2011-2018
Title: Yihui Chen: Innovator in Cancer Treatment Technologies
Introduction
Yihui Chen is a prominent inventor based in Amherst, NY (US), known for his significant contributions to cancer treatment technologies. With a total of 4 patents, Chen has focused on developing innovative solutions that enhance the effectiveness of photodynamic therapy (PDT) for various types of tumors.
Latest Patents
One of Chen's latest patents is a targeting thymidine kinase photosensitizer and pharmaceutical composition for cancer treatment. This invention improves the selectivity of photosensitizers to tumor cells, offering better tolerance and achieving maximum blood concentration within 24 hours. The technology features a larger conjugated system and a longer absorption wavelength, making PDT more practical and economical. Additionally, it can be utilized for diagnosing and treating prostatic carcinoma through fluorescence imaging guidance. Another notable patent involves metallation enhancements in tumor imaging and PDT therapy. This compound links a metallized tetrapyrollic photosensitizer to a fluorescent dye, ensuring that the photosensitizer does not emit or absorb harmful radiation. Furthermore, Chen has developed a method for determining the effectiveness of PDT by comparing the proportions of STAT-3 monomer and crosslinked STAT-3 dimer post-treatment.
Career Highlights
Throughout his career, Yihui Chen has worked with various organizations, including Health Research, Inc. and Zhejiang Hisun Pharmaceutical Co., Ltd. His work has significantly advanced the field of cancer treatment, particularly in the area of photodynamic therapy.
Collaborations
Chen has collaborated with notable professionals in his field, including Ravindra Kumar Pandey and Heinz Baumann. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
Yihui Chen's work in cancer treatment technologies exemplifies the impact of innovation in medical science. His patents and collaborations continue to pave the way for more effective therapies, ultimately benefiting patients worldwide.